Title:Discovery and Optimization of Pyrazoline Derivatives As Promising Monoamine Oxidase Inhibitors
VOLUME: 12 ISSUE: 20
Author(s):Daniela Secci, Simone Carradori, Adriana Bolasco, Bruna Bizzarri, Melissa D’Ascenzio and Elias Maccioni
Affiliation:Department of Drug Chemistry and Technologies, "Sapienza" University of Rome, P.le A. Moro 5, 00185 Rome, Italy.
Keywords:Alzheimer’s disease, antidepressant agents, isocarboxazid, monoamine oxidase, parkinson’s disease, pyrazoline
Abstract:Among different heterocyclic chemotypes incorporating two nitrogen atoms, pyrazolines could be considered a
valid pharmacophore for the synthesis of selective monoamine oxidase (MAO) inhibitors because they were developed by
the cyclization of the early hydrazine derivatives such as isocarboxazid. Substituted pyrazolines, decorated with different
functional groups, are important lead compounds endowed with a large amount of biological activities. As a matter of this,
most of them were also evaluated as dual inhibitors with a synergistic action towards different classes of enzymes (ciclooxygenase,
acetylcholinesterase, butyrylcholinesterase). Moreover due to the direct correlation with the recognized
MAO inhibition, this scaffold displayed antidepressant and anticonvulsant properties in animal models.
